As many as one in three women treated for breast cancer undergo unnecessary procedures, but a new method for diagnosing it could do a better job distinguishing between benign and aggressive tumors.
Researchers at the University of Michigan are developing a pill that makes tumors light up when exposed to infrared light, and they have demonstrated that the concept works in mice.
Mammography is an imprecise tool. About a third of breast cancer patients treated with surgery or chemotherapy have tumors that are benign or so slow-growing that they would never have become life-threatening, according to a study out of Denmark last year. In other women, dense breast tissue hides the presence of lumps and results in deaths from treatable cancers. All that, and mammograms are notoriously uncomfortable.
“We overspend $4 billion per year on the diagnosis and treatment of cancers that women would never die from,” said Greg Thurber, U-M assistant professor of chemical engineering and biomedical engineering, who led the team. “If we go to molecular imaging, we can see which tumors need to be treated.”
The move could also catch cancers that would have gone undetected. Thurber’s team uses a dye that responds to infrared light to tag a molecule commonly found on tumor cells, in the blood vessels that feed tumors and in inflamed tissue. By providing specific information on the types of molecules on the surface of the tumor cells, physicians can better distinguish a malignant cancer from a benign tumor.
Compared to visible light, infrared light penetrates the body easily—it can get to all depths of the breast without an X-ray’s tiny risk of disrupting DNA and seeding a new tumor. Using a dye delivered orally rather than directly into a vein also improves the safety of screening, as a few patients in 10,000 can have severe reactions to intravenous dyes. These small risks turn out to be significant when tens of millions of women are screened every year in the U.S. alone.
But it’s not easy to design a pill that can carry the dye to the tumor.
“To get a molecule absorbed into the bloodstream, it needs to be small and greasy. But an imaging agent needs to be larger and water-soluble. So you need exact opposite properties,” Thurber said.
Fortunately, they weren’t the only people looking for a molecule that could get from the digestive system to a tumor. The pharmaceutical company Merck was working on a new treatment for cancer and related diseases. They got as far as phase II clinical trials demonstrating its safety, but unfortunately, it wasn’t effective.
“It’s actually based on a failed drug,” Thurber said. “It binds to the target, but it doesn’t do anything, which makes it perfect for imaging.”
The targeting molecule has already been shown to make it through the stomach unscathed, and the liver also gives it a pass, so it can travel through the bloodstream. The team attached a molecule that fluoresces when it is struck with infrared light to this drug. Then, they gave the drug to mice that had breast cancer, and they saw the tumors light up.
The research is described in a study in the journal Molecular Pharmaceutics, titled, “Oral administration and detection of a near-infrared molecular imaging agent in an orthotopic mouse model for breast cancer screening.”
The Latest on: Breast cancer diagnosis
[google_news title=”” keyword=”breast cancer diagnosis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Breast cancer diagnosis
- Return to work, work productivity loss and activity impairment in Chinese breast cancer survivors 12-month post-surgery: a longitudinal studyon February 22, 2024 at 8:35 pm
IntroductionExisting evidence of returning-to-work (RTW) after cancer comes predominately from Western settings, with none ...
- Hear from 8 women diagnosed with cancer who spent time at NC State's Poe Hallon February 22, 2024 at 8:21 pm
Eight women who spent time in Poe Hall and were diagnosed with cancer speak publicly Sandy Alford was diagnosed with breast cancer in 2021 after studying for years at Poe Hall. “NC State has taught us ...
- Presence of unmet social needs associated with lower utilization of breast cancer screening programson February 22, 2024 at 4:01 pm
Having a greater number of unmet social needs was associated with lower utilization of screening mammography services, as well as a later stage of breast cancer at the time of diagnosis. Evidence ...
- Kaitlyn Dever Mourns Death of Mom from Breast Cancer: 'I Will Be Broken Forever Without You'on February 22, 2024 at 10:26 am
The actress's mom was diagnosed with stage 4 metastatic breast cancer 14 years ago when she was 39 years old Jamie McCarthy/Getty Kaitlyn Dever is mourning her mother Kathy, whom she called her "best ...
- Guerdy Abraira Shaves Her Head amid Breast Cancer Journey During Emotional “RHOM” Finale: 'The Only Thing I Can Control'on February 22, 2024 at 9:27 am
The 'Real Housewives of Miami' star said “that hair is going to fall off on my terms” before beginning chemotherapy treatment for breast cancer ...
- Kaitlyn Dever mourns mother's passing from breast cancer: 'Thank you for fighting so hard for us for so long'on February 22, 2024 at 9:14 am
Kaitlyn Dever mourns mother's passing from breast cancer: 'Thank you for fighting so hard for us for so long' ...
- Family plans wedding for Leeds mum in six days after breast cancer diagnosis with six months to liveon February 22, 2024 at 3:30 am
A family planned a wedding for a Leeds mum and a baptism for her baby in just six days - after she was given just six months to live.
- A Black woman's breast cancer diagnosis led to a community of survivors embracing natural beauty productson February 21, 2024 at 10:18 am
Tiah Tomlin-Harris created an online support group in her hometown of Atlanta for other women on their cancer journey, called My Style Matters.
- A Black woman's breast cancer diagnosis led to a community of survivors embracing natural beauty productson February 21, 2024 at 3:18 am
Phyllis Stewart, a two-time breast cancer survivor and member of My Style Matters, said the organization has been by her side since she was diagnosed with cancer. She is now a volunteer and ...
via Bing News